Liang X, Etches J, Pinzaru B, et al. - In diabetes patients with and without a history of cancer, researchers compared indicators of diabetes quality of care using the Electronic Medical Record Administrative data Linked Database (EMRALD), a database of Ontario primary care EMR charts linked to administrative data. People with a history of cancer were matched to those without cancer at a 1:2 ratio on age, gender, and duration of diabetes. Using a matched cohort analysis, they compared the recommended diabetes quality of care indicators among individuals with and without cancer. They found 2,275 cancer patients and 4,550 matched controls among 229,627 patients with diabetes; diabetes was diagnosed after cancer in 86.5% of participants. There were no variations between the groups in the recommended clinical testing or in achieving A1C and blood pressure goals. Compared with diabetes patients without cancer of similar age, gender, and diabetes duration, cancer survivors with diabetes are less likely to receive recommended cardiovascular risk‐reducing therapies. Cancer patients with diabetes were significantly less likely to be prescribed ACE inhibitors or angiotensin receptor blockers, receive statin therapy if age 50‐80 years, and achieve an LDL cholesterol level <2.0mmol/L, compared to controls.